Oncology (minimal residual disease [MRD]), next-generation targeted sequencing analysis, cell-free DNA, initial (baseline) assessment to determine a patient specific panel for future comparisons to ev at Medical City Argyle

Compare to other hospitals

See Oncology (minimal residual disease [MRD]), next-generation targeted sequencing analysis, cell-free DNA, initial (baseline) assessment to determine a patient specific panel for future comparisons to ev pricing across every hospital in the network reporting it, or ask Claude or any MCP client directly — see how to connect.